---
category: news
title: "BRIEF-Cynata Therapeutics Gets Ethics Approval To Commence Clinical Trial In Covid-19"
excerpt: "RECEIVES ETHICS APPROVAL TO COMMENCE CLINICAL TRIAL IN COVID-19 AND CLINICAL DEVELOPMENT UPDATE * APPROVAL FOR CLINICAL TRIAL TO TEST"
publishedDateTime: 2020-05-08T01:12:00Z
webUrl: "https://www.reuters.com/article/brief-cynata-therapeutics-gets-ethics-ap-idUSFWN2CP1PS"
ampWebUrl: "https://mobile.reuters.com/article/amp/idUSFWN2CP1PS"
cdnAmpWebUrl: "https://mobile-reuters-com.cdn.ampproject.org/c/s/mobile.reuters.com/article/amp/idUSFWN2CP1PS"
type: article
quality: 88
heat: 88
published: false

provider:
  name: Reuters
  domain: reuters.com
  images:
    - url: "https://insideout.app/coronavirus/assets/images/organizations/reuters.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - Coronavirus

images:
  - url: "https://s4.reutersmedia.net/resources_v3/images/rcom-default.png"
    width: 1200
    height: 630
    title: "BRIEF-Cynata Therapeutics Gets Ethics Approval To Commence Clinical Trial In Covid-19"

secured: "JLe27RoKySXmON7O/UGNsYJ+HOctjgTr3E9K962kQDcck+oYzttl9fHvAfsh10WKKHWkCPgREL/TvNGjMXvTpUJtcGctSwYHTfkcqGqLcEwa0Kpjv1u2gnmNH73uf9OhwfgOrrFy1/Xn95eBF2rRCqaHHFOzNTY8TB1mfJ/EDZcnbKD+6pcpObwRUkznhWOeoyEqE1kK2Ve3at+aJU7zzlwpbkPEBjU8JRHXoCiQoLGwYNdpEQV/2LrxfSmDoog9GxeEi2koo46x0DJlYtZlko9x7bWApcGElblyZtIvqc0g3xzFBl8bjMR5nRxbxx5q;qy6zAkW2xmWHJNn1AlrcrQ=="
---

